查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1973886

聚醚砜医用膜市场：按膜类型、孔径、灭菌方法、销售管道、应用和最终用户划分——2026-2032年全球预测

Polyethersulfone Medical Membrane Market by Membrane Type, Pore Size, Sterilization Method, Sales Channel, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，聚醚砜医用膜市场价值将达到 23.4 亿美元，到 2026 年将成长至 24.4 亿美元，到 2032 年将达到 32.9 亿美元，复合年增长率为 4.96%。

主要市场统计数据
基准年 2025 23.4亿美元
预计年份：2026年 24.4亿美元
预测年份 2032 32.9亿美元
复合年增长率 (%) 4.96%

本次报告将简要介绍聚醚砜医用膜的引入，包括其材料特性、临床意义、製造技术的进步以及法规环境。

聚醚砜医用膜已成为临床和工业过滤应用的核心组件，因其坚固耐用、耐化学腐蚀和生物相容性而备受青睐。这些膜可满足从血液接触透析过滤器到生物製药生产中的精密分离等各种严苛功能，同时也能满足城市和工业用水的净化需求。聚合物化学和製造精度的进步提高了薄膜的一致性并降低了性能差异，使其在临床应用中得到更广泛的推广，并能更紧密地整合到受监管的生产环境中。

随着技术创新改变临床通讯协定并演变采购重点，医用膜的策略角色正在被重新定义。

由于技术创新、临床通讯协定的演变以及采购模式的改变，聚醚砜医用膜的市场环境正经历着一场变革。膜工程技术已从基本的孔隙率控制发展到能够优化抗污染性和选择性渗透性的技术，包括表面改质、梯度孔结构和混合层状结构。这些改进使得膜筒和膜组件能够实现更长的使用寿命和可预测的过滤特性，从而影响设备设计和安装人员的信心。

对美国贸易政策调整对医疗膜产业筹资策略、供应链柔软性和区域製造能力的影响进行评估。

美国2025年实施的关税和贸易政策调整对全球先进医疗零件的供应链、筹资策略和采购成本结构产生了连锁反应。製造商和采购负责人根据到岸成本和不断变化的竞争格局调整了采购决策，不仅关注单价，还关注近岸外包、供应商多元化和总到岸成本分析。这种调整促使供应链经理制定多层次的紧急时应对计画，以平衡在地采购需求与取得海外专业製造能力之间的关係。

将应用案例、膜结构、孔隙分类、灭菌要求、客户类型和销售管道与战略重点联繫起来的详细細項分析。

细分市场分析揭示了不同应用、薄膜规格、孔径分类、最终用户、灭菌方法和销售管道的需求驱动因素和运作要求各不相同。按应用领域划分，相关人员对生物製药、血液滤过、血液透析和水处理领域的薄膜进行评估。血液透析进一步细分为高通量和低通量两种应用场景，其性能和检验需求各不相同。基于膜类型的分类将行业分为两类：板式膜和中空纤维膜，每种膜都有其独特的模组化整合、污染特性和包装注意事项。基于孔径的分类将膜分为微过滤、奈米过滤、逆渗透和超过滤，其中超过滤本身又细分为高截留分子量和低截留分子量，这决定了蛋白质结合特性和处理能力之间的权衡。

区域趋势和监管条件影响美洲、欧洲、中东、非洲和亚太地区的采用、製造策略和商业性定位。

区域趋势对技术采纳、供应链结构和监管合规性有显着影响。在美洲，人们越来越重视检验临床疗效并将其与复杂的医疗采购系统整合，这鼓励了对本地生产的投资以及与监管申报的密切协调。该地区的法规结构和报销机制影响产品设计和上市后监测策略，要求供应商不仅证明产品的安全性和有效性，还要证明其营运效率和生命週期价值。

竞争对手和供应商的策略强调技术差异化、检验的灭菌通讯协定、应用工程和持续的客户支援。

竞争格局呈现出多元化的特点，既有专业薄膜製造商，也有整合组件供应商，还有利用先进聚合物加工技术的新兴参与企业。主要企业凭藉强大的技术支援能力、检验的灭菌通讯协定和完善的品质系统脱颖而出，从而更容易获得临床和生物製药领域的监管核准。那些投资于应用工程团队并与原始设备製造商 (OEM) 和契约製造紧密合作的供应商，在获取产品规格和签订长期合约方面取得了更高的成功率。这种合作关係有助于降低整合风险，并缩短整套医疗设备和一次性组件的上市时间。

供应商加强技术差异化、业务永续营运、监管合规性和客户伙伴关係模式的实用策略重点

医疗膜领域的领导企业必须采取协作策略，使产品开发、品质系统和商业性执行与不断变化的客户需求保持一致。优先投资于表面工程和孔结构优化，以延长功能寿命并减少污染，同时确保这些技术进步能够透过标准化测试和临床检验来确认。同时，也应加强法规遵循和品管能力，简化仪器集成，并支援全球市场进入，包括提供灭菌相容性和萃取物测试的证明文件。

为了确保研究结果具有可重复性和实用性，我们采用了一种高度透明和严谨的调查方法，该方法结合了专家访谈、文献整合和情境分析。

本分析的调查方法整合了第一手和第二手信息，以得出严谨且可重复的评估结果。一级资讯来源包括对采购经理、临床技术人员和生产主管的结构化访谈，以及对聚合物科学家和膜製程工程师的专家技术访谈。这些访谈提供了关于验证重点、对灭菌性能的预期以及买方在选择膜类型和孔径等级时可接受的操作权衡的定性见解。

透过将材料创新、监管要求、供应链韧性和商业性可行性整合到一项结论性分析中，我们提出了一个一致的策略展望。

分析表明，聚醚砜医用膜在临床、生物製药和工业过滤应用中发挥核心作用，其性能期望日益与耐灭菌性、可製造性以及可证实的临床和製程优势挂钩。材料创新和製造自动化不断提升技术标准，而采购惯例和贸易政策的变化则凸显了供应链敏捷性和区域製造能力的重要性。这些因素共同推动着产业转向那些兼具技术差异化、完善的品质系统和灵活的商业模式的供应商。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：聚醚砜医用膜市场（依膜类型划分）

  • 平板
  • 中空纤维膜

第九章：聚醚砜医用膜市场（依孔径划分）

  • 过滤
  • 奈米过滤
  • 逆渗透
  • 超过滤
    • 高截止频率
    • 低截止频率

第十章：聚醚砜医用膜市场（以灭菌方法划分）

  • 高压釜灭菌
  • 环氧乙烷
  • 伽玛射线照射

第十一章：聚醚砜医用膜市场：依销售管道划分

  • 直销
  • 透过分销商销售
  • 电子商务

第十二章：聚醚砜医用膜市场：依应用领域划分

  • 生物製药
  • 血液过滤
  • 血液透析
    • 高通量
    • 低通量
  • 水处理

第十三章：聚醚砜医用膜市场：依最终用户划分

  • 诊所
  • 医院
  • 製药公司
  • 研究所

第十四章：聚醚砜医用膜市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章：聚醚砜医用膜市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章：聚醚砜医用膜市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国聚醚砜医用膜市场

第十八章：中国聚醚砜医用膜市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3M Company
  • Asahi Kasei Corporation
  • Cobetter Filtration Co., Ltd.
  • GE Healthcare, Inc.
  • Graver Technologies, LLC
  • Hyflux Ltd.
  • Koch Membrane Systems, Inc.
  • Meissner Filtration Products, Inc.
  • Membrana GmbH
  • Merck Millipore Corporation
  • Microdyn-Nadir GmbH
  • Pall Corporation
  • Parker-Hannifin Corporation
  • Pentair plc
  • PEXCO, Inc.
  • Sartorius AG
  • Solvay SA
  • Sterlitech Corporation
  • Thermo Fisher Scientific Inc.
  • Toray Industries, Inc.
Product Code: MRR-5D340F440B52

The Polyethersulfone Medical Membrane Market was valued at USD 2.34 billion in 2025 and is projected to grow to USD 2.44 billion in 2026, with a CAGR of 4.96%, reaching USD 3.29 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.34 billion
Estimated Year [2026] USD 2.44 billion
Forecast Year [2032] USD 3.29 billion
CAGR (%) 4.96%

Concise introduction to polyethersulfone medical membranes highlighting material properties clinical significance manufacturing evolution and regulatory context

Polyethersulfone medical membranes have emerged as a cornerstone component across clinical and industrial filtration applications, valued for their robustness, chemical resistance, and biocompatibility. These membranes serve an array of demanding functions, from blood-contacting dialysis filters to precision separations in biopharmaceutical processing, while also addressing municipal and industrial water purification needs. Advances in polymer chemistry and manufacturing precision have improved membrane consistency and reduced variability in performance, enabling broader clinical adoption and tighter integration into regulated manufacturing environments.

As stakeholders evaluate material selection and process integration, several intersecting forces shape decision-making. Regulatory scrutiny and patient safety priorities require suppliers to demonstrate sterilization compatibility, extractables and leachables control, and stable performance under repeated use or aggressive cleaning cycles. Concurrently, OEMs and healthcare providers pursue operational efficiency and traceability, driving demand for membranes that can be reliably validated and scaled. On the manufacturing side, investments in automated casting and fiber spinning technologies have reduced defect rates and improved throughput, supporting tighter lead times and more predictable supply. Given these dynamics, polyethersulfone membranes are increasingly viewed not merely as components but as engineered subsystems that influence clinical outcomes, manufacturing yields, and lifecycle costs.

Transitioning from material attributes to market relevance, an effective introduction recognizes the interplay between clinical need, manufacturability, and regulatory compliance. This framing prepares readers to interpret subsequent analysis through the lenses of technological capability, supply chain resilience, and stakeholder expectations, setting the stage for actionable insights that follow.

How technological advancements shifting clinical protocols and evolving procurement priorities are redefining the strategic role of medical membranes

The landscape for polyethersulfone medical membranes is experiencing transformative shifts driven by technological innovation, evolving clinical protocols, and changing procurement models. Membrane engineering has advanced beyond basic porosity control to encompass surface modification, gradient pore architectures, and hybrid laminate constructions that optimize fouling resistance and selective permeability. These enhancements allow membrane cartridges and modules to achieve higher functional lifetimes and more predictable filtration profiles, which in turn influence device design and installer confidence.

Clinically, there is a growing emphasis on patient-centric care pathways that rely on more compact and efficient extracorporeal systems, prompting membrane designers to prioritize high-flux performance and biocompatibility. Simultaneously, the biopharmaceutical sector's shift toward single-use processing and intensified downstream operations has increased demand for membranes that maintain integrity under sterilization stress and exhibit minimal adsorption of biologics. Procurement strategies are also shifting: larger healthcare systems and contract manufacturers increasingly negotiate service-level agreements and long-term supply contracts that favor suppliers who can demonstrate consistency, traceability, and responsive technical support.

Another notable shift concerns sustainability expectations. End users and regulators are scrutinizing lifecycle impacts, encouraging suppliers to reduce solvent use, optimize polymer recycling where feasible, and design membranes compatible with lower-energy sterilization methods. Taken together, these trends are converging to elevate membranes from commodity items to strategic components that influence product differentiation, regulatory approval timelines, and long-term operating costs. For decision-makers, understanding these shifts is essential to align R&D investments and commercial strategies with emergent customer priorities.

Assessment of how United States trade policy adjustments influenced sourcing strategies supply chain agility and regional manufacturing responses in the medical membrane space

The imposition of tariffs and trade policy adjustments originating from the United States during 2025 produced ripple effects across global supply chains, sourcing strategies, and procurement cost structures for advanced medical components. Manufacturers and buyers recalibrated sourcing decisions in response to altered landed costs and altered competitive dynamics, driving increased attention to nearshoring, supplier diversification, and total landed-cost analysis rather than unit price alone. This recalibration has prompted supply chain managers to develop layered contingency plans that balance local content requirements with access to specialized manufacturing capacity located abroad.

As a consequence, some suppliers accelerated investments in regional manufacturing capabilities to reduce exposure to tariff volatility and to serve prioritized markets with shorter lead times. Contract manufacturers and OEMs scrutinized their bill of materials to identify elements vulnerable to trade measures, and they engaged in more frequent contractual review cycles to allocate tariff risk. Procurement teams expanded their use of scenario-based sourcing models to stress-test supplier portfolios, operationalizing alternative logistics routes and multi-sourcing arrangements to mitigate potential disruptions.

The tariffs also intensified collaboration between regulatory and procurement functions to ensure that any supplier substitutions maintained compliance with device labeling, regulatory approvals, and sterilization validation. For companies that rely on integrated supply partnerships, the policy environment highlighted the importance of advanced data visibility into supply chains and the need for contractual clauses that address trade policy shifts. Ultimately, the cumulative impact of these trade measures underscored the importance of strategic flexibility, stronger supplier relationships, and an ability to adapt product and sourcing strategies rapidly when geopolitical forces alter the commercial landscape.

In-depth segmentation insights that link application use cases membrane architectures pore classification sterilization requirements customer types and sales channels to strategic priorities

Segmentation analysis reveals differentiated demand drivers and operational requirements across applications, membrane formats, pore classifications, end users, sterilization approaches, and sales channels. Based on Application, stakeholders evaluate membranes across Biopharmaceutical, Blood Filtration, Hemodialysis, and Water Treatment, with Hemodialysis further dissected into High-Flux and Low-Flux use cases that carry distinct performance and validation needs. Based on Membrane Type, the industry splits between Flat Sheet and Hollow Fiber formats, each presenting unique module integration, fouling behavior, and packaging considerations. Based on Pore Size, membranes are categorized into Microfiltration, Nanofiltration, Reverse Osmosis, and Ultrafiltration, where Ultrafiltration itself subdivides into High-Cut-Off and Low-Cut-Off classes that dictate protein-binding characteristics and throughput trade-offs.

In parallel, end user segmentation shows distinct purchasing priorities: Clinics, Hospitals, Pharmaceutical Companies, and Research Laboratories each apply different procurement frameworks, tolerances for innovation, and technical support expectations. Sterilization Method matters materially; membranes compatible with Autoclaving, Ethylene Oxide, and Gamma Irradiation must demonstrate sustained performance and undergo rigorous validation to satisfy clinical and manufacturing stakeholders. From a commercialization perspective, Sales Channel segmentation through Direct Sales, Distributor Sales, and E-commerce influences buyer experience, price transparency, and aftermarket service models.

Integrating these segmentation dimensions yields actionable implications. For instance, manufacturers targeting high-flux hemodialysis must align product development with sterile manufacturing and hospital procurement cycles, while suppliers focusing on biopharmaceutical single-use applications prioritize low-protein-binding ultrafiltration membranes with validated gamma irradiation compatibility. Those serving water treatment applications emphasize durability, chemical resistance, and regulatory compliance with municipal standards. Ultimately, a multidimensional segmentation lens helps executives prioritize R&D, quality systems, and go-to-market investments to match the nuanced needs of each customer cohort.

Regional dynamics and regulatory landscapes that influence adoption manufacturing strategies and commercial positioning across the Americas Europe Middle East and Africa and Asia-Pacific

Regional dynamics shape technology adoption, supply chain architecture, and regulatory engagement in material ways. In the Americas, demand has tended to emphasize clinical validation and integration with complex healthcare procurement systems, prompting local manufacturing investments and close coordination with regulatory submissions. Regulatory frameworks and reimbursement structures in the region encourage suppliers to demonstrate not only safety and efficacy but also operational efficiency and lifecycle value, which influences product design and post-market surveillance strategies.

Across Europe, Middle East & Africa, the landscape is more heterogeneous, with rigorous regulatory standards in some jurisdictions and emerging market requirements in others. Suppliers operating in this region must navigate varied conformity assessment pathways, differing sterilization standards, and complex cross-border logistics. This environment rewards flexible regulatory affairs capabilities, adaptable packaging and labeling strategies, and distributors with deep local market expertise. It also places a premium on demonstrating environmental stewardship and compatibility with circular economy expectations increasingly emphasized by regional authorities.

In the Asia-Pacific region, rapid capacity growth, a strong manufacturing base, and expanding clinical and industrial demand combine to create both opportunities and competitive pressures. Local manufacturers have scaled capacity, benefitting from integrated supply networks and cost advantages, while regional buyers often prioritize rapid delivery and competitive pricing. However, increasing regulatory harmonization efforts and greater emphasis on clinical evidence are elevating product quality expectations. For global suppliers, success in Asia-Pacific requires both competitive cost structures and demonstrable compliance with evolving regional regulatory norms.

Competitive dynamics and supplier strategies that emphasize technical differentiation validated sterilization protocols application engineering and sustained customer support

The competitive landscape is characterized by a mix of specialized membrane manufacturers, integrated component suppliers, and new entrants leveraging advanced polymer processing. Leading organizations differentiate through technical support capabilities, validated sterilization protocols, and strong quality systems that facilitate regulatory approvals in clinical and biopharmaceutical contexts. Suppliers who invest in application engineering teams and collaborate closely with OEMs and contract manufacturers generate stronger specification wins and longer-term contracts, since these relationships reduce integration risk and accelerate time to market for finished medical devices and single-use assemblies.

Manufacturers that emphasize process reliability-demonstrating consistent performance across sterilization cycles and batch-to-batch reproducibility-tend to retain larger accounts and secure preferred-supplier status. Strategic partnerships with research institutions and clinical centers also serve as important catalysts for product validation and adoption, enabling iterative improvements and early clinical feedback loops. New entrants often find opportunity in niche segments, such as high-cut-off ultrafiltration for specialized bioprocess operations or tailored hollow fiber formats for compact therapeutic devices, where technical differentiation can overcome scale disadvantages.

Across the landscape, aftermarket services and technical training distinguish market leaders from competitors. Organizations that provide comprehensive validation support, on-site training, and rapid replacement services are better positioned to capture long-term value. For incumbent suppliers, continuous improvement of manufacturing controls and investment in automation provide defenses against cost competition and help assure customers of long-term supply stability.

Actionable strategic priorities for suppliers to strengthen technical differentiation operational resilience regulatory compliance and customer partnership models

Leaders in the medical membrane space must pursue coordinated strategies that align product development, quality systems, and commercial execution with evolving customer needs. Prioritize investments in surface engineering and pore architecture optimization to extend functional lifetimes and reduce fouling, while ensuring these technical advances are verifiable through standardized testing and clinical validation. Simultaneously, strengthen regulatory and quality affairs capabilities to streamline device integration and support global market access, including well-documented sterilization compatibility and extractables testing.

To mitigate supply chain exposure, diversify supplier footprints and consider regional manufacturing to improve responsiveness and reduce geopolitical risk. Build deeper partnerships with key customers by offering integration support, custom validation packages, and training that shorten adoption cycles and enhance retention. From a commercial perspective, refine channel strategies to balance direct account management for strategic buyers with distributor and e-commerce approaches for broader market coverage, ensuring consistent technical support and traceability across channels.

Finally, embed sustainability into product roadmaps and operations by optimizing solvent use, enhancing polymer efficiency, and exploring end-of-life considerations that align with customer and regulatory expectations. These initiatives should be accompanied by transparent data reporting and lifecycle assessments that support procurement decisions. By executing on these priorities, industry leaders can secure performance differentiation, operational resilience, and stronger long-term partnerships with healthcare providers and manufacturers.

Transparent and rigorous research methodology combining expert interviews literature synthesis and scenario analysis to ensure reproducible and actionable insights

The research methodology underpinning the analysis synthesizes primary and secondary sources to produce a rigorous and reproducible assessment. Primary inputs include structured interviews with procurement leaders, clinical engineers, and manufacturing executives, supplemented by expert technical interviews with polymer scientists and membrane process engineers. These dialogues provided qualitative insights into validation priorities, sterilization performance expectations, and the operational trade-offs buyers accept when selecting membrane formats and pore classes.

Secondary sources encompass peer-reviewed technical literature, regulatory guidance documents, standard test protocols, and publicly available product specifications. Data triangulation was applied to reconcile differing perspectives, with a focus on establishing consistent patterns in supplier differentiation, sterilization compatibility, and end-user preferences. Scenario analysis and sensitivity checks explored how shifts in trade policy, sterilization practice, and clinical adoption patterns could influence supplier strategies and procurement behavior.

Quality assurance steps included independent peer review of technical assertions, cross-validation of supplier claims against publicly disclosed validation data, and reproducibility checks on classification logic for segmentation and regional analysis. Throughout the research process, emphasis was placed on traceability of sources and transparency of assumptions to ensure that findings can be confidently applied by decision-makers for strategic planning and operational change.

Concluding synthesis that links material innovation regulatory expectations supply chain resilience and commercial execution into a coherent strategic outlook

The analysis demonstrates that polyethersulfone medical membranes occupy a pivotal role across clinical, biopharmaceutical, and industrial filtration applications, with performance expectations increasingly linked to sterilization resilience, manufacturability, and demonstrable clinical or process benefits. Material innovation and manufacturing automation are raising the technical bar, while procurement practices and trade policy shifts have underscored the importance of supply chain agility and regional manufacturing capabilities. Together, these forces are steering the industry toward suppliers who can pair technical differentiation with strong quality systems and flexible commercial models.

For stakeholders, the takeaway is clear: success depends on a holistic approach that integrates product engineering, regulatory foresight, and supply chain strategy. Whether addressing high-flux hemodialysis demands, supporting single-use bioprocess workflows, or supplying durable membranes for water treatment, alignment across R&D, quality, and commercial teams will determine the ability to capture long-term value. Moving forward, organizations that invest in validated performance, build resilient supplier networks, and deliver compelling post-sale support will be best positioned to navigate evolving clinical standards and market expectations.

In conclusion, polyethersulfone membranes remain central to filtration innovation; translating that technical promise into sustained market performance requires coordinated investment and clear execution across the product lifecycle.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Polyethersulfone Medical Membrane Market, by Membrane Type

  • 8.1. Flat Sheet
  • 8.2. Hollow Fiber

9. Polyethersulfone Medical Membrane Market, by Pore Size

  • 9.1. Microfiltration
  • 9.2. Nanofiltration
  • 9.3. Reverse Osmosis
  • 9.4. Ultrafiltration
    • 9.4.1. High-Cut-Off
    • 9.4.2. Low-Cut-Off

10. Polyethersulfone Medical Membrane Market, by Sterilization Method

  • 10.1. Autoclaving
  • 10.2. Ethylene Oxide
  • 10.3. Gamma Irradiation

11. Polyethersulfone Medical Membrane Market, by Sales Channel

  • 11.1. Direct Sales
  • 11.2. Distributor Sales
  • 11.3. E-commerce

12. Polyethersulfone Medical Membrane Market, by Application

  • 12.1. Biopharmaceutical
  • 12.2. Blood Filtration
  • 12.3. Hemodialysis
    • 12.3.1. High-Flux
    • 12.3.2. Low-Flux
  • 12.4. Water Treatment

13. Polyethersulfone Medical Membrane Market, by End User

  • 13.1. Clinics
  • 13.2. Hospitals
  • 13.3. Pharmaceutical Companies
  • 13.4. Research Laboratories

14. Polyethersulfone Medical Membrane Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Polyethersulfone Medical Membrane Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Polyethersulfone Medical Membrane Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Polyethersulfone Medical Membrane Market

18. China Polyethersulfone Medical Membrane Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. 3M Company
  • 19.6. Asahi Kasei Corporation
  • 19.7. Cobetter Filtration Co., Ltd.
  • 19.8. GE Healthcare, Inc.
  • 19.9. Graver Technologies, LLC
  • 19.10. Hyflux Ltd.
  • 19.11. Koch Membrane Systems, Inc.
  • 19.12. Meissner Filtration Products, Inc.
  • 19.13. Membrana GmbH
  • 19.14. Merck Millipore Corporation
  • 19.15. Microdyn-Nadir GmbH
  • 19.16. Pall Corporation
  • 19.17. Parker-Hannifin Corporation
  • 19.18. Pentair plc
  • 19.19. PEXCO, Inc.
  • 19.20. Sartorius AG
  • 19.21. Solvay S.A.
  • 19.22. Sterlitech Corporation
  • 19.23. Thermo Fisher Scientific Inc.
  • 19.24. Toray Industries, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY MEMBRANE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY PORE SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY STERILIZATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY FLAT SHEET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY FLAT SHEET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY FLAT SHEET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HOLLOW FIBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HOLLOW FIBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HOLLOW FIBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY MICROFILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY MICROFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY MICROFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY NANOFILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY NANOFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY NANOFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY REVERSE OSMOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY REVERSE OSMOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY REVERSE OSMOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY ULTRAFILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY ULTRAFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY ULTRAFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY ULTRAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HIGH-CUT-OFF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HIGH-CUT-OFF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HIGH-CUT-OFF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY LOW-CUT-OFF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY LOW-CUT-OFF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY LOW-CUT-OFF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY AUTOCLAVING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY AUTOCLAVING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY AUTOCLAVING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY ETHYLENE OXIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY ETHYLENE OXIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY ETHYLENE OXIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY GAMMA IRRADIATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY GAMMA IRRADIATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY GAMMA IRRADIATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY E-COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY BIOPHARMACEUTICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY BIOPHARMACEUTICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY BIOPHARMACEUTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY BLOOD FILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY BLOOD FILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY BLOOD FILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HIGH-FLUX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HIGH-FLUX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HIGH-FLUX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY LOW-FLUX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY LOW-FLUX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY LOW-FLUX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY WATER TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY WATER TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY WATER TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY ULTRAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY ULTRAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY ULTRAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY ULTRAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY ULTRAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY ULTRAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY ULTRAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY ULTRAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY ULTRAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. GCC POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GCC POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. GCC POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. GCC POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY ULTRAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 169. GCC POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 170. GCC POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. GCC POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. GCC POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 173. GCC POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY ULTRAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY ULTRAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. G7 POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. G7 POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. G7 POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 195. G7 POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY ULTRAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 196. G7 POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 197. G7 POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 198. G7 POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. G7 POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 200. G7 POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. NATO POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. NATO POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. NATO POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 204. NATO POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY ULTRAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 205. NATO POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 206. NATO POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 207. NATO POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. NATO POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 209. NATO POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY ULTRAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY PORE SIZE, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY ULTRAFILTRATION, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA POLYETHERSULFONE MEDICAL MEMBRANE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)